Please login to the form below

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology

[Image: From left, FIDE Directors Richard GB Langley, MD; Richard Warren, MD, PhD; Kenneth B Gordon, MD; Bruce E Strober, MD, PhD] 

November 10, 2021, UK. Fishawack Health, the leading commercialization partner for the life science industry, welcomes FIDE to its group—an independent expert-led consultancy specializing in chronic inflammatory skin conditions and offering independent expert insight from leading dermatologists.

FIDE’s global healthcare experts provide biopharmaceutical companies with unique insights from early phase research to real-world evidence post-approval. The organization’s subscription and bespoke consultancy services arm clients with the knowledge needed to clearly understand the critical issues for improving health outcomes for patients across the globe while also achieving business success.

With the addition of FIDE, Fishawack Health’s clients can access a network of renowned global experts, including the organization's directors:

  • Bruce E Strober, MD, PhD, Clinical Professor of Dermatology at Yale University School of Medicine and Central Connecticut Dermatology in Cromwell, CT
  • Kenneth B Gordon, MD, Professor and Chair of Dermatology at the Medical College of Wisconsin
  • Richard GB Langley, MD, Director, Professor and Director of Research in the Division of Dermatology, Dalhousie University
  • Richard Warren, MD, Professor and Director of the Dermatopharmacology Unit at the University of Manchester in the UK

Fishawack Health’s support for FIDE cements its commitment to solving the vast unmet needs of patients with chronic inflammatory skin conditions. Biopharmaceutical companies are increasingly focusing their attention on developing treatments for these dermatological conditions, with more than 80 products in development to treat atopic dermatitis and psoriasis. This increase in research and development has created a crowded market and an abundance of data that healthcare professionals often find challenging to navigate. With FIDE’s specialists, Fishawack Health can better equip its dermatology clients with the knowledge and skills necessary to meet their stakeholders' complex and evolving needs.

Bruce Strober, MD, PhD, Executive Director at FIDE, explains: “There is a fantastic opportunity for life science companies to better support dermatologists in navigating the innovations launching in the next few years. By joining Fishawack Health, we can connect our knowledge of the field with Fishawack Health’s deep expertise in services supporting clients through the product lifecycle to help life science companies transform patients’ lives.”

“FIDE is a compelling addition to our group,” says Group President Gail Flockhart. “The company’s expert-led approach provides our clients with insights into a highly innovative and complex market with significant unmet patient needs. We have worked with FIDE for more than a decade, and our partnership has been tremendously successful in supporting clients with access to expert insight. We are delighted to continue to deliver this work and to develop the service offering further now they are fully part of the group.”

Jonathan Koch, Fishawack Health CEO, adds: “I’m incredibly excited to welcome such a talented team to our organization. FIDE’s key opinion leaders will add a unique lens to our services for our dermatology clients—one that I have not seen before in the agency and consulting worlds. When combined with our team's expertise across the product life cycle, we can solve an array of complex challenges for our clients, empowering them with novel solutions that truly get to the heart of healthcare professionals' and patients' challenges.”

Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 1,300+ globe-spanning pack of strategic, creative, and scientific experts. Weempower healthcare professionals and patients with the knowledge they need to live better lives.

Our core operating units—Medical, Marketing, Market Access, and Consulting—bring together best-in-class capabilities from around the world. We empower our pharmaceutical, biotech, and medical technology clients to navigate the most complex of ecosystems, helping them on an effective path to develop, launch, and grow their brands, services, and portfolios.

Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, Fleet, London, Knutsford, Manchester, Oxford, and Sale), Ireland (Dublin), the USA (Chicago, Evansville, Minneapolis, New York, Philadelphia, San Diego, Scottsdale, and St. Louis), Greece (Athens), and Singapore.

Visit us at and follow us on Twitter and LinkedIn.

About FIDE

FIDE is a full-service consultancy with extensive expertise in the pathophysiology, clinical presentation, and treatment of chronic inflammatory diseases, including psoriasis, psoriatic arthritis, atopic dermatitis, and hidradenitis suppurativa.

FIDE’s expert-led approach differs from conventional consultancy by providing biotechnology and pharmaceutical companies with direct and unfiltered healthcare professional engagement. Working collaboratively with you, FIDE will enable you to clearly visualize the critical issues for patient care and optimize your business.

Visit us at and follow us on LinkedIn.

Fishawack Health contacts  

UK Contact: 

Natasha Cowan

FIDE contact: 

Steve Annels

10th November 2021



Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

No. 3 Booths Park
Booths Hall
Chelford Road
WA16 8GS
United Kingdom

Latest content on this profile

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology
Fishawack Health
Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders
In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.
Fishawack Health
How we’re empowering our teams to fight healthcare inequality
Welcoming Sheena Amin-Liebman as our new Diversity and Inclusion Director. Sheena will play a vital role in creating an inspiring environment that empowers staff to better guide its clients in their work to improve health outcomes for the patients they serve.
Fishawack Health
Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access
Sotiria Papanicolaou, Chief Consulting Officer at PRMA Consulting, a member of Fishawack Health, explains how the combination of digital innovation and expert insight are removing roadblocks and speeding up the generation of health technology assessments (HTA) and payer submissions for pharma.
Fishawack Health
Future focus: 3 tools for launching fast in the face of uncertainty
Dan Twibell, Head of Commercial Strategy, Consulting at Fishawack Health, reveals 3 fundamental tools for lean biotechs approaching a rapid launch. He gives his advice on how to manage resources effectively and ensure the strategy remains agile in a changing market landscape.
Fishawack Health
Fishawack Health appoints new CEO, Jonathan Koch
Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.
Fishawack Health